eli lilly retatrutide trials Shows 28% Weight Loss in 80 Weeks Retatrutide, Eli Lilly’s Next-Gen Obesity

The researchers reviewed 20 patients with CT or MRI imaging both before and after starting GLP-1 receptor agonists

Toss asparagus spears with a teaspoon of olive oil, salt, and pepper

Chronic kidney disease and risk management: standards of medical care in diabetes-2022

Night sweats, early waking, fragmented sleep, and slower muscle recovery all pile on in a way that mimics medication side effects

Focus on glucagon-like peptide-1 target: drugs approved or designed to treat obesity

Commonly prescribed GLP-1 receptor agonists in the UK include semaglutide (marketed as Wegovy for weight management and Ozempic for diabetes) and liraglutide (Saxenda for weight management and Victoza for diabetes)